Intalight Unveils Global Launch of 186° True-Color Ultra-Widefield Fundus Camera, Marking a 'Deepseek Moment' in Ophthalmic Diagnosis

A core contradiction in the global ophthalmic diagnostic equipment market remains unresolved:The Impossible Coexistence of Ultra-Wide Angle Screening Needs and High-Definition True Color Diagnosis Needs.The technical binary paradox has not only long trapped fundus camera devices in the development dilemma of pseudo-color lesion bias and limited true-color angles, but has also become a chasm standing in the way of precise ophthalmic diagnosis. Until recently,Intalight's New Generation True Color Ultra-Wide Angle Camera - Ruyi True Color Camera Global Launch, breaking the deadlock just now. Thus far, the Intalight Ruyi series has achieved comprehensive generational leadership, ushering in the Deepseek era for ophthalmic diagnostics!

Intalight Saiwei Ruyi True Color Camera

Recently, Intalight's Ruyi True Color Camera made its global debut during the 26th Fundus Disease Forum and International Retina Symposium (Retina China 2025) held in Wuxi.Professor Xu Xun from Shanghai First People's Hospital, Professor Wang Ningli from Beijing Tongren Hospital, Professor Li Xiaoxin from Xiamen University Affiliated Xiamen Eye Center, and other expert teams, as well as SaiweiProf. Andre Romano from the NeoVista Retina Center in Brazil and Prof. John Miller from Harvard Medical SchoolExperts, etc., have all given strong affirmation to this new generation true color ultra-wide-angle camera. Upon its release, the new product immediately attracted industry attention. Ophthalmology experts and scholars focused on the product's technological breakthroughs and deeply discussed its application value in the diagnosis and treatment of fundus diseases, praising the heights achieved by domestically produced ophthalmic equipment.

The revolutionary value of Intalight's TrueChrome camera lies in the completion of true color imaging technology.Breadth and ClarityThe dual disruption has redefined the industry standard for ophthalmic imaging equipment.

Based on its self-developed optical system, Intalight's Ruyi True Color Camera achieves8-Source Continuous SpectrumImaging, which can restore the true color of the fundus and achieve "What You See Is What You Get (WYSIWYG)"; compared to the previous generation of true-color ultra-widefield cameras, it captures a larger field of view——Single-shot imaging range can reach 186°, the true color area has increased by 90%, with the maximum mosaic reaching up to 280°; the optical resolution has successfully broken through to 6.8μm,Balancing true color, breadth, and clarity, it brings an unparalleled experience to clinical research, teaching, and doctor-patient communication, setting a new benchmark for ultra-widefield imaging.

Behind the revolutionary technological breakthrough, Intalight's R&D team has overcome challenges in fundamental optical structure design, core technical details, assembly and debugging, as well as clinical needs based on self-developed technology.Intalight Founder/Chairman/CTO Dr. Peng Xianzhao, who previously focused on the semiconductor industry, led the design of semiconductor inspection equipment lenses at the same level as lithography machines., which deeply migrates the ultra-precision optical design concepts from the semiconductor lithography field to the research and development of ophthalmic equipment.

Dr. Peng Xianzhao

It was Dr. Peng who led the team to tackle the challenge with a rigorous scientific research methodology. Through optical theory analysis and computer simulation, they traced each source one by one and optimized the optical design parameters. Meanwhile,Intalight Co-Founder/CEO Dr. Li Bing, an expert in image processing, software engineering, and artificial intelligence, leads the team to achieve breakthroughs such as true color calibration through algorithm optimization.

Dr. Li Bing

ThisTheoretical Origin, Simulation Verification, Design IterationThe R&D model, as well as inOptical Design, Algorithm Optimization, Process PrecisionEqual DimensionsSeveral times the effort has also enabled Intalight to achieveCross-disciplinary Technology Integration and Generational Breakthroughs in Fundus Cameras。

In addition to Dr. Peng Xianzhao and Dr. Li Bing, several top talents from Silicon Valley have joined Intalight, forming a world-class, cross-border and cross-disciplinary R&D team composed of Silicon Valley semiconductor engineers, top scholars in science, and returned doctors. From a team of top scholars to leading experts in Silicon Valley's semiconductor and medical imaging fields, Intalight is dedicated to building a core R&D team that spans optics, algorithms, clinical research, and engineering, driving industry innovation with technical strength.

Currently, Saiwei has formed a coverage ofIntalight's Ruyi Series Ophthalmic Diagnosis Matrix Centered on Ultra-Widefield True Color Camera, Biometer, and Swept-Source OCT. These three devices are the most commonly used and technologically valuable diagnostic tools in ophthalmic clinics, collectively forming the foundation of ophthalmic diagnostic equipment. In this process,Every product of Saiwei strives to be the global leader in its niche market, surpassing existing global benchmark products and achieving comprehensive generational superiority.

·Intalight Camera——A new generation of true color ultra-wide-angle camera, achieving larger and clearer fundus images. With 8-source continuous spectrum true color imaging technology, a single imaging range reaches 186°, true color area increased by 90%, maximum stitching up to 280°, optical resolution breaking through 6.8μm, comprehensively improving the efficiency of diagnosis, teaching, and doctor-patient communication for fundus diseases.

·Intalight Full-Eye Biometer——The 2nd Generation Visualized Swept-Source Biometry Technology, a one-stop solution for IOL implantation planning. Utilizing Intalight's patented optical design, the upgraded TrueFix™ Panoramic Fundus Visualization Measurement Mode increases axial detection rate from less than 95% with the 1st generation swept-source biometer to over 99%, enabling precise measurements and one-stop IOL planning.

Intalight Full-Eye Biometer

·DREAM OCT——A New Generation Swept-Source OCT: Full-Eye Imaging Combined with Multi-Lens Flexible Optical Solution, a Powerful Tool for Precise Ophthalmic Diagnosis. Relying on the new generation swept-source laser technology, it has the world's widest fundus imaging capability, with a single 150° ultra-wide-angle OCTA imaging, automatic stitching up to 250°, far surpassing the field of view of traditional OCT, with a maximum depth imaging of 16.2 mm and a speed of up to 400,000 scans/sec, achieving a comprehensive surpass of similar products at home and abroad.

DREAM OCT (DREAM OCT)

In terms of commercial performance, Intalight's OCT products have achieved particularly outstanding results in both the Chinese and international markets. The products have contributed to the publication of more than 180 high-level SCI research papers, including the world’s first definition and naming of three types of conditions, as well as three covers of globally renowned journals. They have gained high recognition in the clinical and research work of international ophthalmology experts worldwide.

WithIn May this year, Intalight's full-eye OCT received EU CE certification, and Intalight's global layout is further accelerating.Joe Garibaldi, Chief Business Officer of Intalight, stated that after obtaining CE certification, Intalight will continue to expand the application of this disruptive technology and broaden clinical collaborations with more globally leading institutions and authoritative ophthalmology experts.

Intalight's Full-Eye OCT Receives EU CE Certification

According to official data, the cumulative installation volume of Intalight's full-eye OCT exceeds550 units, OCT sales onceRanked first in China's market share for two consecutive years，OCT Market Share Exceeds 50% in the First Quarter of 2025Intalight OCT Continues to Lead the High-End Ophthalmic Equipment Market in China.

It is worth mentioning that in recent years, Intalight has been constantly expanding into the international market and has established in-depth cooperation with more than 30 top ophthalmic institutions overseas, includingBascom Palmer Eye Institute, University of Miami, Harvard Medical School, Stanford University, UCLA Doheny Eye Institute, Moorfields Eye Hospital in the UK, Vienna General Hospital, Medical University of Vienna, Tokyo Medical and Dental University in Japanetc., the equipment was affectedProfessor Philip Rosenfeld, Professor Ricky Wang, Professor David Huang, Professor SriniVas SaddaBy globally renowned ophthalmology experts.

A careful study of Saiwei's overseas layout reveals that,Saiwei, relying on the Silicon Valley startup genes of its team, continues to attract and cultivate R&D and clinical talents with rich experience., and through overseas laboratories and R&D centers, provide support for new product development. This layout not only accelerates technological iteration but also enhances innovation efficiency by integrating global resources.

Nowadays, as Intalight's overseas approved product portfolio continues to expand, combined with the in-depth layout of its global R&D, operational systems, and channel networks, Intalight's overseas market scale is expected to gradually surpass that in China, forming a feedback loop for the company’s technology development.

At the same time, IntalightIn-depth layout of the full range of ophthalmic product lines, such as the full femtosecond laser surgery system, high-end surgical microscopes, and intelligent data platforms, etc., achieving full-chain innovation in ophthalmology from diagnosis to treatment, and striving to build a global high-end ophthalmic platform company. Among them, the all-femtosecond laser surgery system has completed the optical system design equivalent to the difficulty of lithography machines and finished the manufacturing of engineering prototypes.

Next, Intalight will collaborate with global ophthalmology authorities to focus on the innovation of modern optical technology empowered by AI. By promoting the deep integration of optical imaging and AI algorithms, it will continuously redefine ophthalmic diagnosis and treatment standards. At the same time, it will expand product boundaries to create a full-chain technology solution covering the entire eye health cycle for global ophthalmologists and patients, from precise diagnosis to personalized treatment.